tiprankstipranks
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA

Atara Biotherapeutics (ATRA) Financial Statements

1,069 Followers

Atara Biotherapeutics Financial Overview

Atara Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-36.697; its P/E ratio is -0.21; Atara Biotherapeutics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-2.15. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 27.36M$ 2.14M$ 957.00K--
Gross Profit$ 27.36M$ 4.75M$ 957.00K--
EBIT$ -55.95M$ -68.42M$ -69.73M$ -73.41M$ -74.32M
EBITDA$ -54.56M$ -67.21M$ -68.53M$ -72.20M$ -75.62M
Net Income Common Stockholders$ -31.75M$ -64.57M$ -71.11M$ -74.77M$ -74.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 46.24M$ 102.41M$ 153.79M$ 205.55M$ 242.97M
Total Assets$ 165.27M$ 188.79M$ 246.44M$ 302.08M$ 376.42M
Total Debt$ 42.20M$ 48.51M$ 51.75M$ 54.92M$ 58.06M
Net Debt$ -4.04M$ -53.90M$ -102.03M$ -150.63M$ -184.90M
Total Liabilities$ 263.58M$ 239.63M$ 238.99M$ 237.12M$ 249.78M
Stockholders Equity$ -98.31M$ -50.84M$ 7.45M$ 64.96M$ 126.64M
Cash Flow-
Free Cash Flow$ -29.74M$ -51.60M$ -53.30M$ -38.83M$ -56.92M
Operating Cash Flow$ -29.61M$ -51.35M$ -52.80M$ -38.43M$ -56.88M
Investing Cash Flow$ 14.72M$ 70.45M$ 49.48M$ -6.01M$ 51.22M
Financing Cash Flow$ 24.14M$ -208.00K$ 471.00K$ 235.00K$ 32.29M
Currency in USD

Atara Biotherapeutics Earnings and Revenue History

Atara Biotherapeutics Debt to Assets

Atara Biotherapeutics Cash Flow

Atara Biotherapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis